Uhk kons indb

Kaynaklar

1.  Dutton RP, Hess JR, Scalea TM. Recombinant 

Factor VIIa for control of hemorrhage: Early expe-

rience in critically ill travma patients. Journal of 

Cilinical Anesthesia 2003, 15: 184-188.

2.  Chakraverty R, Davidson S, Peggs K et al. The 

incidence and cause of coagulopathies in an 

intensive care population. Br J Haematol 1996; 

93: 460-463.

3.  Strauss R, Wehler M, Mehler K, Kreutzer D, Koeb-

nick C, Hahn EG: Thrombocytopenia in patients 

in the medical intensive care unit: bleeding pre-

valence, transfusion requirements, and outcome. 

Crit Care Med 2002, 30:1765-1771.

4.  Levi M, Opal SM. Coagulation abnormalities in 

critically ill patients. Critical Care 2006, 10 (4): 

1-9.

5.  Levi M, Schultz M. Coagulopathy and platelet 

disorders in critically ill patients. Minerva Aneste-

siologica 2012; 76 (10): 851-859.

6.  Stephan F, Hollande J, Richard O, Cheffi A, Maier-

Redelsperger, M, Flahault A: Thrombocytopenia in 

a surgical ICU. Chest 1999, 115:1363-1370.

7.  Hanes SD, Quarles DA, Boucher BA: Incidence 

and risk factors of thrombocytopenia in critically 

ill trauma patients. Ann Phar-macother 1997, 

31:285-289.

8.  Vanderschueren S, De Weerdt A, Malbrain M, 

Vankersschaever D, Frans E, Wilmer A, Bobbaers 

H: Thrombocytopenia and prognosis in intensive 

care. Crit Care Med 2000, 28:1871-1876.

9.  Rice TW, Wheeler AP. Coagulopathy in critically 

ill patients: Part 1: Platelet disorders. Chest 2009; 

136: 1622-1630.

10. Teitel JM. Clinical approach to the patients with 

unexpected bleeding. Clin Lab. Haem 2000; 22 

(Suppl.1): 9-11. 

11. Başlar Z. Kanama eğilimli hastaya yaklaşım. In: 

Altıparmak MR (ed). Sürekli Tıp Eğitimi Etkinlik-

leri, İç Hastalıklarında Aciller, 2010; p: 403-425.

12. Nilsson G, Astermark J, Lethagen S et al. The 

prognostic value of global haemostatic tests in the 

intensive care unit setting. Acta Anaesthesiologica 

Scandinavica 2002; 46: 1062-1067.

13. Harrison P, Robinson M, Liesner R et al. The 

PFA-100: a potential rapid screening tool for 

the assessment of platelet dysfunction. Clin Lab 

Haem. 2002; 24: 225-232. 

14. Hematology in Clinical Practice. Hillman RS, Ault 

KA, Leporrier M, Rinder HM (eds). 2012, McGraw-

Hill. ISBN: 978-975-277-404-9.

15. Hematology, Basic Principles nad Practice. Hoff-

man R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, 

Silberstein LE, McGlave P, Heslop H, eds (2009) 

5th edition. Churchill Livingstone.

16. Tekgündüz E, Soysal T. Yoğun Bakımda Kanama 

Bozuklukları ve Tedavi. Yoğun Bakım Derneği 

Dergisi 2005; Cilt:3, Sayı:2: 65-75.

17. Gezer  S.  Dissemine  İntravasküler Koagülasyonun 

Tanı ve Tedavisi. Hematolog 2012; 2 (2): 97-111.

18. Johansson PI, Hansen MB, Sorensen H. Transfu-

sion practice in massively bleeding patients: time 

for a change? Vox Sang, 2005: 1-5.

19. Türk Hematoloji Derneği, Edinsel Kanama Bozuk-

lukları ve Kalıtsal Trombofili, Tanı ve Tedavi Kıla-

vuzu, sürüm 1-Temmuz 2011

20. Thachil J, Toh CH. Mission: İmpossible-DIC Pro-

tocol. Coagulation problems in intensive care. 

Hematology education: EHA 2012; 6 (1): 147-152.

21. Levi M. Current understanding of disseminated 

intravascular coagulation. British Journal of Hae-

matology; 124: 567-76.

22. Levi M, Toh CH, Thachil J, Watson HG. Guidelines 

for the diagnosis and management of dissemi-

nated intravascular coagulation. Br J Haematol 

2009; 145: 24-33.

23. Annotation. The management of coumarin-indu-

ced over-anticoagulation. Br J Haematol 2001; 

114: 271-280.